I-Rabeprazole Sodium CAS 117976-90-6 Purity >99.5% (HPLC) API Factory

Incazelo emfushane:

Igama Lekhemikhali: I-Rabeprazole Sodium

I-CAS: 117976-90-6

Ubumsulwa: >99.5% (HPLC)

Ikristalu Eliphuzi Kancane ukuya Eliphuzi Kancane noma Impushana

I-API, i-Anti-Ulcer, i-Proton Pump Inhibitor

E-Mail: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Chemical Properties:

Igama Lekhemikhali I-Rabeprazole Sodium
Omqondofana I-2-([4-(3-Methoxypropoxy)-3-Methylpyridin-2-yl]methylsulfinyl)-1H-Benzo[d]imidazole;I-Pariprazole
Inombolo ye-CAS 117976-90-6
Isimo Sesitoko Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula I-C18H20N3NaO3S
Isisindo samangqamuzana 381.42
I-Melting Point 140.0 ~ 141.0℃
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka Ikristalu Eliphuzi Kancane ukuya Eliphuzi Kancane noma Impushana;I-Hygroscopic
I-Infrared Spectrum Ivumelana Nesakhiwo
I-Proton NMR Spectrum Ivumelana Nesakhiwo
I-ICP Iqinisekisa Ingxenye Yesodium
Ukuncibilika Incibilika Ngokuphelele Emanzini;I-Soluble Kakhulu ku-Ethanol, i-Chloroform;I-Soluble ku-Methanol
pH 9.5~12.0
Ukulahlekelwa Ekumisweni <1.00%
Izinsimbi Ezisindayo <20ppm
Izinto Ezihlobene (HPLC)
Ukungcola A <0.80%
Ukungcola Okungashiwongo <0.20%
Ukungcola Okuphelele <1.00%
Izincibilikisi Ezisele (GC)
I-Methylene Chloride <600ppm
I-Ethanol <5000ppm
I-Isopropyl Ether <5000ppm
I-acetone <5000ppm
Umkhawulo weMicrobial
I-Aerobe Count ≤1000CFU/g
Isikhunta Nembiliso Kubalwa ≤100CFU/g
E. Coli Ayikho ngegremu ngayinye
Ukuhlanzeka / Indlela Yokuhlaziya >99.5% (HPLC, Isisekelo Esomisiwe)
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa I-API ye-Anti-Ulcer

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama

Izinzuzo:

1

I-FAQ:

Isicelo:

I-Rabeprazole Sodium (i-CAS: 117976-90-6) iyi-proton pump inhibitor ecindezela ukukhiqizwa kwe-gastric acid esiswini.Inokusetshenziswa okuningana kwezokwelapha: ukulawulwa kwezimo ezibandakanya ukukhiqizwa kwe-asidi esesiswini ngokweqile (isb. I-Zollinger-Ellison syndrome), izimo ezimbi kakhulu ngenxa ye-asidi esiswini (isb. izilonda emgudwini wesisu), nezimo ezibandakanya ukuchayeka isikhathi eside ku-asidi yesisu (isb. isifo se-reflux ye-gastroesophageal).I-Rabeprazole nayo iyasiza kanye nokwelashwa ngama-antibiotic ekwelapheni i-pathogen i-Helicobacter pylori, echumayo endaweni ene-asidi.Ngakho-ke, i-Rabeprazole Sodium iyi-FDA egunyazwe ukwelashwa kwe-GERD enezimpawu entsheni nakubantu abadala, ukuphulukisa izilonda ze-duodenal kubantu abadala, ukuqedwa kwe-Helicobacter pylori, kanye nezimo ze-pathologic hypersecretory.I-Rabeprazole Sodium icindezela ukukhiqizwa kwe-asidi esiswini ngokuvimbela i-H+/K+ATPase yesisu (i-hydrogen-potassium adenosine triphosphatase) endaweni eyimfihlo yeseli ye-gastric parietal.

Bhala umyalezo wakho lapha futhi usithumelele wona